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Resistance to antibiotics is the biggest
challenge we are facing this century.
Antimicrobial resistance (AMR) threatens
the effective prevention and treatment
of an ever-increasing range of infections
caused by bacteria, parasites, viruses,
and fungi. Antimicrobials - including
antibiotics, antivirals, antifungals and
antiparasitic - are medicines used to
prevent and treat infections in humans,
animals and plants. Microorganisms that
develop antimicrobial resistance are
sometimes referred to as “superbugs”.
Since the discovery of the first antibiotics Penicillin in 1928 there has been
continued worry that bacteria can develop resistance. This is a significant danger
because it can result in infections becoming more dangerous, causing long term
illnesses, burden on country health budgets and related morbidity. Country health
infrastructure, prescribing behaviors, overuse and misuse of antibiotics, health
related regulations and awareness about use of antibiotics among public are
important contributing factors.
Antibiotics are a precious resource as they safeguard us against infections. We
should also consider the “Discovery void” which is the time since the discovery
of last antibiotic – 1987. Our choices are not increasing, the arsenal is limited, and
we need to preserve it and use wisely. There is an urgent need to understand and
change the way antibiotics are prescribed and used. Without changing the behavior
and augmenting the health infrastructure this threat is not going anywhere, soon.
The rise in antimicrobial resistance is extremely high in all parts of the world.
New patterns and mechanism of resistance are prevalent and rapidly spreading
worldwide. Sharply decreasing our common infection treating ability. It is
anticipated that 70% of antibiotic resistance is ascending in the Asia regions and
Pakistan is no different. Both Multi-Drug Resistant (MDR) and Extensively Drug
Resistant (XDR) bacteria have been identified in Pakistan also. Many commonly
used antibiotics are now ineffective against several commonly occurring infections.
Antibiotic Overuse prevails in Pakistan as Pakistan is ranked 3rd among Lowincome Nations with Antibiotic consumptions increasing from 0.8 to 1.3 billion
Daily Defined doses (DDD) depicting a massive 65 Per cent rise in the year 2000
and 2015.
A study conducted on prevalence and pattern of self-medication in Karachi
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revealed that more than 80% people use self-medication and upon worsening of symptoms a medical store technician
is consulted before a visit to a consultant is being made. However, sales of non-prescribed antibiotics are completely
restricted by National Drug Policy. Such antibiotics can easily be purchased from pharmacies easily as more than 90 %
are operational without a qualified pharmacist.
According to the Pakistan Medical Association (PMA), Approximately 600K unregistered medical practitioners pose
a real threat to public health. The main way these quacks inflict harm is by prescribing antibiotics without having the
knowledge and understanding of the indication and no credentials.
Each of us can contribute our own part to stop the resistance developing via,
1. We should only use antibiotics when prescribed.
2. Complete the therapy duration as per the prescription.
3. Never recommend antibiotics to friends and family and never share leftover antibiotics.
4. Following WHO Five keys to safer food (keep clean, separate raw and cooked, cook thoroughly, keep food at safe
temperatures, use safe water and raw materials).
5. Always select pharmacies where pharmacists are dispensing after proper review of medications.
6. Healthcare practitioners can contribute via focusing on their prescriptions and only prescribing antibiotics when
needed.
7. Counseling patient proper on the use of antibiotics, how to take them correctly, the resistance to them and hazards
related to their misuse. Patient should also be informed about prevention of infections (For Example, Timely 		
Vaccination, Hand washing and basic hygiene practices.
Government also has a key role to contribute and following lines of action can contribute as mentioned below,
l

l
l

l

Ensure a robust national action plan to tackle antibiotic 		
resistance is in place.
Improve surveillance of antibiotic-resistant infections.
Augment policies, programs, and implementation of Prevention
of infections and measures to control.
Promote and regulate appropriate use and disposal of quality
medicines.

l

Drug regulators should also monitor registration and national consumption of antibiotics.

l

Information related to the impact of antimicrobial resistance to be made public.

l

Regulating agriculture sector and control use of antibiotic in animals only under veterinary supervision.

While there are new antibiotics in development around the world, none of them are expected to provide cure for the most
dangerous forms Antibiotic resistant bacteria. Stopping resistance to Antibiotics requires serious efforts from all countries
and many important sectors. We can slow it down by changing our behaviors and respecting this life saving resource.
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PinPoint Pupil, What’s your Guess?
Faqeeha Shakeel, Pharmacist
Case: A 2.5 yrs old child presented in Emergency Department of a private
hospital at 14:00 hrs with the pinpoint pupil, nausea vomiting and foamy
secretions. The child has ingested some powdered material around 9
am. Initially child was stable and asymptomatic but after few hours of
ingestion child started showing symptoms of vomitings and foamy secretions so the
parents rushed towards the ER for management.
Upon examination , the child had pin point pupil and secretions, Doctors start treating
in line of Organophosphate Poisoning but after sometimes patient started bruising. The
coagulation profile for lab testing was sent and found out elevated INR. Family showed
an empty sachet of ‘Rodenticide ( Rat Killer) that was found in the room suggestive of
anticoagulants.
Finally , the child was administered “vitamin K” IV: 2 to 5 mg as an anti-antidote for
rodenticide. He was also given Intravenous Atropine and Pralidoxime for cholinergic
crisis till symptoms resolves.

Background
l

l

l

Anticoagulants (blood
thinners) are found in most
rat poison products, and are
responsible for more than
50% of rodenticide poisoning.
Rodents quickly became
resistant to it, and as a result,
“superwarfarin” rat poisons
were created that have more
prolonged effects and are at
least 100 times more toxic.
The two superwarfarins
that are responsible for
most rodenticide poisonings
in humans are bromadiolone
and brodifacoum.

Pralidoxime: IV:
Continuous infusion: Infants, Children, and Adolescents ≤16
years: Loading dose: IV: 20 to 50 mg/kg (maximum dose: 2,000
mg/dose); followed by continuous infusion at 10 to 20 mg/kg/
hour.
IV, IM, Atropine:
Infants and Children: Initial: 0.05 to 0.1 mg/kg; repeat every
5 to 10 minutes as needed, doubling the dose if previous dose
does not induce atropinization.
A Query arises that if the child has taken rat killer then what
could be the reason of having pinpoint pupil?
Because It’s not necessary that all rodenticides contain only long
acting anticoagulants, they may contain carbamate pesticides
as well which can lead towards the fulminant cholinergic crises
or cholinergic toxidromes.
And the point to be considered is : ALWAYS Treat the Patient (as per symptoms) , Not the POISON”
Note: Keep all medications, chemicals and caustic agents out of reach of children. For any accidental ingestion , Call at
Drug & Poison Information Centre, AKUH 021-34861504/ 1506
Reference : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3027455/
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Recent Approvals by US-FDA
New treatment option for Trichomoniasis
Trichomoniasis is a genitourinary infection with the protozoan Trichomonas vaginalis. Women are affected more
often than men. Trichomoniasis is one of the three common infectious causes of vaginal complaints among reproductiveaged women. However, the infection is often asymptomatic. Adults with trichomoniasis are typically treated with seven
days of oral Metronidazole or Tinidazole. The US Food and Drug Administration recently approved expanding the
use of Secnidazole to include treatment of trichomoniasis in addition to previous approval for treatment of bacterial
vaginosis. While the single two grm (2 gm) oral dosing may be appealing and improve patient compliance with
treatment, comparative efficacy data with multiday treatments are not yet available and cost may be higher.

New drug treatment option for Vulvovaginal candidiasis
Vulvovaginal candidiasis refers to vaginal and vulval symptoms caused by a yeast, most often Candida albicans. It
affects 75% of women on at least one occasion over a lifetime. Oral and topical Azole drugs, such as Fluconazole, are
the mainstay for treatment of vulvovaginal candidiasis. Ibrexafungerp is a new oral triterpenoid antifungal for single
day treatment of uncomplicated vulvovaginal candidiasis in post-menarchal females . This drug may be helpful for
those with azole allergy or adverse effects or who have azole-resistant infection. The safety profile of this drug is not
well established in pregnancy and lactation.

Adverse Drug Reactions (ADR) & Warning Update
Risk of GI bleeding with Direct Oral Anticoagulation (DOACs)
Direct oral anticoagulants (DOACs) that includes Rivaroxaban, Apixaban , Dabigatrin & Edoxaban are generally preferred
over warfarin in individuals with non-valvular atrial fibrillation or venous thromboembolism.
A new study evaluated the risk of gastrointestinal (GI) bleeding in over 5000 individuals taking apixaban, rivaroxaban, or
dabigatran. Higher rates of GI bleeding were seen in individuals taking rivaroxaban (3.2 per 100 patient-years) than with
the other agents (2.5 for apixaban and 1.9 for dabigatran). The once-daily dosing of rivaroxaban and higher peak levels
may explain the higher bleeding risk; the other agents are dosed twice daily. These results may be a consideration when
choosing among DOACs.

Booster Doses of COVID-19 Vaccines in adults
Hafsah Ashfaq, Clinical Pharmacist
There is a lot of information in the news right now about COVID-19 booster shots.
Similar to the rationale behind giving boosters for those illnesses, COVID-19 booster shots can help your body maintain
a higher level of immunity and protection against breakthrough COVID-19 infections. A breakthrough infection occurs
when someone who is fully vaccinated gets COVID-19. That person can still get sick—although most vaccinated people
will have milder symptoms—and they can spread COVID-19 to others.
Government of Pakistan is cognizant of the evolving need and rationale for additional / booster doses in specific segments
of the population.
The following categories of individuals are eligible for a single, additional / booster Covid-19 vaccine dose.
1. Immunocompromised persons of all eligible age groups
2. Citizens, 50 years of age and above
3. Healthcare workers
NOTE: The Interval from last known dose received by the individual MUST be at least 28 days; and the 2nd additional dose (if required) is to be administered 21-28
days after the first additional dose for Pfizer/Sinopharm , Sinovac and other relevant vaccines respectively.
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Covid -19 Vaccine in Paediatric Population:
FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age.The
Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age is administered as a two-dose primary
series, 3 weeks apart, but is a lower dose (10 micrograms) than that used for individuals 12 years of age and older (30
micrograms).
Reference : USFDA

Top Reported Errors Associated to COVID-19 Vaccination Globally
Faqeeha Shakeel, Pharmacist
Error

Description

Prevention

Shoulder injury related
to vaccine administration
(SIRVA)

SIRVA is inflammation and injury to the shoulder
tendons, ligaments, or bursa triggered by the
incorrect injection of a vaccine into the shoulder
joint instead of the deltoid muscle.

Patients should be told to completely expose their
shoulder when receiving an IM vaccine. Health care
workers correctly identify the deltoid muscle.

Not documenting in the
Immunization Management
System

Majority of the COVID-19 vaccines are of two
doses, if not documented in Immunization
Management System than chances of getting
second dose will be delayed.

Patients & Staff are given a vaccination card that
documents the vaccine type and date administered.

Wrong diluent

The Pfizer Covid-19 vaccine requires
mixing ONLY with sterile 0.9% sodium chloride
(preservative-free). Bacteriostatic normal saline
or any other diluent should never be used.

Double check of dilution under the direction of the
pharmacy, dispense prefilled, labeled syringes of the
vaccine for daily vaccination.

Wrong diluent volume

The multiple-dose vial of the Pfizer/BioNTech
vaccine contains a volume of 0.45 mL, supplied
as a frozen concentrated suspension that does not
contain preservative. Each vial must be thawed
and diluted with 1.8 mL of 0.9% sodium chloride
injection

A properly diluted Pfizer/BioNTech vaccine vial holds
2.25 mL and allows for at least 6 doses.

Errors related to vaccine
storage

Vaccines being mixed up in storage, including
reports of vaccines being mixed up with
insulin and neuromuscular blockers.

Store the vaccines in separate locations or on separate
shelves. In addition, do not place the vaccines close to
any other medications.

Mix-ups with other
medications during
administration

In one reported case, 2 patients accidentally were
given an EPINEPHrine injection instead of the
COVID-19 vaccine.

COVID-19 vaccination sites should stock separately.
This error happens because of epinephrine injections
(for anaphylaxis reactions) stored with Vaccines.

Administration of air in
empty vaccine syringe

The empty syringes often are placed near
syringes that are prefilled with vaccine but not
labeled. Just as these empty syringes filled with
air have been used accidentally injected into
patients instead of vaccine.

Again, independent double checks and having
pharmacy dispense prefilled, labeled syringes can help
to prevent such errors.

Wrong dose

Due to vaccine leakage from the syringe because
of poor needle attachment to the syringe. Some
individuals have received a dose lower than
authorized.

Before administration of any dose, check for a tight fit
between the needle hub and the syringe.

Vaccine competency

Many errors, such as drawing up incorrect
vaccine volume and SIRVA, often are due to
competency issues.

Be sure that staff screening patients and administering
vaccines are educated about the storage, preparation,
and administration

Reference:
ISMP. Problems with Guangdong Haiou syringes for COVID-19 vaccinations. ISMP Medication Safety Alert! April 22, 2021;26(8).
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Drug Safety Communication: Alcohol-based Hand Sanitizer Getting in the Eyes Can Cause Serious Injury (November 2021)
Hafsah Ashfaq, Clinical Pharmacist
Using hand sanitizers is one of the most widely used safety measures, especially during the COVID-19 pandemic, as it
is quick and efficient. However, hand sanitizers can also lead to serious problems. Many cases of children showing up to
hospitals with hand sanitizer in their eyes have been reported. Some cases were so serious that blindness was possible.
The U.S. Food and Drug Administration (FDA) is warning that getting alcohol-based hand
sanitizer in the eyes from splashing or touching the eyes after use of hand sanitizer can result in
serious injury, including severe irritation and damage to the surface of the eye. For 4 cases from
U.S. poison control center calls between January 1, 2018, and April 30, 2021, 3,642 cases of side
effects resulting from eye exposure to these hand sanitizers as high concentration ethanol based hand sanitizers are strong
enough to kill the corneal cells.
In May 2020, in France, just 16.4% of kids got sanitizer in their eyes from public dispensers, whereas by August 2020,
the number increased to 52.4%.
First Aid :
l
l

		
l

		

Don’t let the eyes rub. This should be avoided “at all costs” because it can make the problem worse.
Wash out the affected eye for ten minutes with warm water. If possible, have them hold the heads under the tap,
so water can run into their eyes and out, flushing out the sanitizer.
If burning and stinging continue, or if their vision changes or they experience vision loss, contact an eye doctor
as soon as possible and treat the situation as an emergency.

Note: Keep all medications, chemicals and caustic agents out of reach of children. For any accidental ingestion , Call at
Drug & Poison Information Centre, AKUH 021-34861504/ 1506

Medicine Safety Week: Making Vaccines Better for Everyone
Always report suspected side effects
Together we can make vaccines better
for everyone
For reporting ADR ; please follow link
l
l
l

https://vaems.aku.edu/aems_prod/Default.asp
Use Yellow Cards
Or Call ADR Hotline 1479

Provide us your Valuable Feedback!
Link: https://forms.gle/FCo9ZuE4CConzFp46

The Aga Khan University Hospital, Karachi

